Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

vTv Therapeutics (VTVT) Non Operating Income (2016 - 2025)

Historic Non Operating Income for vTv Therapeutics (VTVT) over the last 10 years, with Q3 2025 value amounting to -$34000.0.

  • vTv Therapeutics' Non Operating Income fell 14000.0% to -$34000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $325000.0, marking a year-over-year increase of 31959.46%. This contributed to the annual value of $160000.0 for FY2024, which is 11068.8% up from last year.
  • As of Q3 2025, vTv Therapeutics' Non Operating Income stood at -$34000.0, which was down 14000.0% from $54000.0 recorded in Q2 2025.
  • Over the past 5 years, vTv Therapeutics' Non Operating Income peaked at $2.9 million during Q2 2021, and registered a low of -$3.6 million during Q3 2023.
  • Moreover, its 5-year median value for Non Operating Income was $35500.0 (2023), whereas its average is -$139166.7.
  • As far as peak fluctuations go, vTv Therapeutics' Non Operating Income crashed by 100322.58% in 2023, and later surged by 185882.35% in 2024.
  • Quarter analysis of 5 years shows vTv Therapeutics' Non Operating Income stood at $634000.0 in 2021, then tumbled by 197.48% to -$618000.0 in 2022, then skyrocketed by 102.75% to $17000.0 in 2023, then surged by 1858.82% to $333000.0 in 2024, then tumbled by 110.21% to -$34000.0 in 2025.
  • Its Non Operating Income stands at -$34000.0 for Q3 2025, versus $54000.0 for Q2 2025 and -$28000.0 for Q1 2025.